These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 8104336

  • 1. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8474-8. PubMed ID: 8104336
    [Abstract] [Full Text] [Related]

  • 2. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    J Clin Invest; 1994 Apr 15; 93(4):1458-64. PubMed ID: 8163650
    [Abstract] [Full Text] [Related]

  • 3. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
    Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Proc Natl Acad Sci U S A; 1995 Jun 20; 92(13):5855-9. PubMed ID: 7597041
    [Abstract] [Full Text] [Related]

  • 4. Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease.
    Miniati DN, Hoyt EG, Feeley BT, Poston RS, Robbins RC.
    Circulation; 2000 Nov 07; 102(19 Suppl 3):III237-42. PubMed ID: 11082394
    [Abstract] [Full Text] [Related]

  • 5. Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.
    Morishita R, Gibbons GH, Tomita N, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.
    Arterioscler Thromb Vasc Biol; 2000 Apr 07; 20(4):915-22. PubMed ID: 10764654
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery.
    Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ.
    Gene; 1994 Nov 04; 149(1):13-9. PubMed ID: 7958977
    [Abstract] [Full Text] [Related]

  • 7. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.
    Simons M, Edelman ER, Rosenberg RD.
    J Clin Invest; 1994 Jun 04; 93(6):2351-6. PubMed ID: 7911126
    [Abstract] [Full Text] [Related]

  • 8. Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides.
    Poston RS, Tran KP, Mann MJ, Hoyt EG, Dzau VJ, Robbins RC.
    J Heart Lung Transplant; 1998 Apr 04; 17(4):349-55. PubMed ID: 9588579
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI.
    J Clin Invest; 1994 Feb 04; 93(2):820-8. PubMed ID: 8113414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen.
    Speir E, Epstein SE.
    Circulation; 1992 Aug 04; 86(2):538-47. PubMed ID: 1353419
    [Abstract] [Full Text] [Related]

  • 16. Endoluminal local delivery of PCNA/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis.
    Robinson KA, Chronos NA, Schieffer E, Palmer SJ, Cipolla GD, Milner PG, King SB.
    Cathet Cardiovasc Diagn; 1997 Jul 04; 41(3):348-53. PubMed ID: 9213035
    [Abstract] [Full Text] [Related]

  • 17. Prevention of intima hyperplasia by mitogen-activated protein kinase antisense oligodeoxynucleotide.
    Huang SL, Ding B, Shan B, Yu QS, Guo ZG.
    Acta Pharmacol Sin; 2000 Apr 04; 21(4):313-7. PubMed ID: 11324457
    [Abstract] [Full Text] [Related]

  • 18. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
    Tomita N, Horiuchi M, Tomita S, Gibbons GH, Kim JY, Baran D, Dzau VJ.
    Am J Physiol; 1998 Aug 04; 275(2):F278-84. PubMed ID: 9691019
    [Abstract] [Full Text] [Related]

  • 19. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty.
    Gunn J, Holt CM, Francis SE, Shepherd L, Grohmann M, Newman CM, Crossman DC, Cumberland DC.
    Circ Res; 1997 Apr 04; 80(4):520-31. PubMed ID: 9118483
    [Abstract] [Full Text] [Related]

  • 20. Antisense suppresssion of protein kinase C-alpha and -delta in vascular smooth muscle.
    Busuttil SJ, Morehouse DL, Youkey JR, Singer HA.
    J Surg Res; 1996 Jun 04; 63(1):137-42. PubMed ID: 8661186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.